Results 161 to 170 of about 1,692,509 (236)

Responses to the Third Lancet Commission on Investing in Health from Denmark, Germany, and Norway. [PDF]

Lancet Reg Health Eur
Alfvén T, Chang AY, Cleaver HO, Hornidge AK, Jensen SLB, Mofoss E, Nilsen FN, Norheim OF, Schäferhoff M, Siegel M, Strupat C.   +10 more
europepmc   +1 more source

Enhancing stock timing predictions based on multimodal architecture: Leveraging large language models (LLMs) for text quality improvement. [PDF]

PLoS One
Chen M, Tang Y, Qi Q, Dai H, Lin Y, Ling C, Li T.   +6 more
europepmc   +1 more source

Entrepreneurs' Opportunities: From Exploratory learning to Entrepreneurial Improvisation. [PDF]

PLoS One
Hong Y, Nie T.
europepmc   +1 more source

Fortifying our commitment to pediatric academic medicine during turbulent times. [PDF]

Pediatr Res
Gera MP, Garg A, Ragavan MI.
europepmc   +1 more source

The Inflation Reduction Act's Impact Upon Early-Stage Venture Capital Investments. [PDF]

Ther Innov Regul Sci
Schulthess DG, O'Loughlin G, Askeland M, Gassull D, Bowen HP.   +4 more
europepmc   +1 more source

Biopharmaceutical pipeline funded by venture capital firms, 2014 to 2024. [PDF]

Health Aff Sch
Kang SY, Liu M, Ballreich J, Gupta R, Anderson G.   +4 more
europepmc   +1 more source

Therapeutic innovations in hemophilia: the essential role of a positive reinvestment cycle. [PDF]

Blood Adv
Hermans C, Pierce GF.
europepmc   +1 more source

Antecedents of the effectiveness of entrepreneurship policy: An integrated framework. [PDF]

PLoS One
Zhang M, Zhang W.
europepmc   +1 more source

Mission and money: A scoping review of social enterprise business models as a solution to sustaining health-promoting food and nutrition-based initiatives. [PDF]

BMC Public Health
Fathi LI, Walker J, Dix C, Previte J, Olgacher D, Woodside J, Truby H.   +6 more
europepmc   +1 more source

The potential of academic drug discovery: successes and challenges. [PDF]

Expert Opin Drug Discov
Stremlau M, Slusher BS.
europepmc   +1 more source